Study Purpose: This study looks at the safety and tolerability of a medicine called iloperidone for adolescents aged 12-17 with schizophrenia or bipolar I disorder. Schizophrenia is a mental health condition that affects how you think, feel, and behave. Bipolar I disorder is a condition where a person has extreme mood swings, including emotional highs (mania) and lows (depression).
Study Duration: The treatment will last up to 52 weeks, which is one year.
Who Can Join: Participants must be between 12 and 17 years old and have either schizophrenia or bipolar I disorder. They must be willing to take part, and their parent or guardian must agree too. They cannot be taking other study drugs or test positive for drugs of abuse.
- Participation Length: Up to 52 weeks of treatment.
- Age Requirement: Must be between 12-17 years old.
- Parental Consent: Needed for participation.
How understandable was the trial content above?
Hard to understand
Easy to understand